The Evolution and Future of Medical Affairs in Biopharma: A Strategic Transformation for the Next Decade

  1. Möller, Gerd
  2. Gerwe, Martin
  3. Häring, Monika ORCID logo

Download
DOI-10.4126FRL01-006511321-PMQM125-p76-94-MA-Future-Moeller-et-al Kopie.pdf 1,96MB
WeightNameValue
1000 Titel
  • The Evolution and Future of Medical Affairs in Biopharma: A Strategic Transformation for the Next Decade
1000 Titelzusatz
  • Medical Affairs from a Supportive Function to a Strategic Pillar
1000 Autor/in
  1. Möller, Gerd |
  2. Gerwe, Martin |
  3. Häring, Monika |
1000 Erscheinungsjahr 2025
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2025-05
1000 Erschienen in
1000 Quellenangabe
  • 27(1):76-94
1000 Embargo
  • 2026-05
1000 Lizenz
1000 Verlagsversion
  • https://www.dgpharmed.de/pm-qm-journal/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Medical Affairs (MA) in the biopharmaceutical industry has undergone a remarkable transformation over the past several decades, evolving from a predominantly supportive function to a strategic pillar alongside Research & Development and Commercial operations. This article examines the historical development, current strategic positioning, and future trajectory of Medical Affairs through 2030. Drawing on industry data, peer-reviewed literature, and strategic analyses from consulting firms, professional societies, and academic journals, we explore how digital transformation, artificial intelligence integration, data-driven approaches, and evolving stakeholder expectations are fundamentally reshaping Medical Affairs functions. The paper highlights emerging competency requirements for Medical Affairs professionals, including digital literacy, systems thinking, and ecosystem orchestration capabilities, while providing comprehensive frameworks for measuring impact and value creation in an increasingly digitalized healthcare ecosystem. Special attention is given to Artificial Intelligence (AI) integration as both a technological tool and a mindset shift, the evolving role of Medical Science Liaisons, and the function’s emerging position as a central ecosystem orchestrator. As Medical Affairs continues its transformation, organizations must navigate implementation challenges including organizational resistance, skills gaps, and regulatory requirements such as the EU AI Act, while balancing ambitious vision with pragmatic execution to capitalize on this evolution and deliver sustainable value to patients, healthcare systems, and their organizations.
1000 Fächerklassifikation (DDC)
1000 DOI 10.4126/FRL01-006511321 |
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TcO2bGxlciwgR2VyZA==|https://frl.publisso.de/adhoc/uri/R2Vyd2UsIE1hcnRpbg==|https://orcid.org/0009-0007-9114-3363
1000 Hinweis
  • Dieses Werk steht nach Ablauf des Embargos von 12 Monaten nach Veröffentlichung in diesem Journal unter einer CC BY 4.0 Lizenz frei zur Verfügung unter: https://doi.org/10.4126/FRL01-006511321
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. The Evolution and Future of Medical Affairs in Biopharma: A Strategic Transformation for the Next Decade
    The Evolution and Future of Medical Affairs in Biopharma: A Strategic Transformation for the Next Decade
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6511321.rdf
1000 Erstellt am 2025-05-14T13:30:13.161+0200
1000 Erstellt von 338
1000 beschreibt frl:6511321
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet 2025-05-26T11:54:14.154+0200
1000 Objekt bearb. Mon May 26 11:54:14 CEST 2025
1000 Vgl. frl:6511321
1000 Oai Id
  1. oai:frl.publisso.de:frl:6511321 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source